Galmed Pharmaceuticals Ltd. sell Bank of America Co.
Start price
06.11.24
/
50%
€6.40
Target price
06.11.25
€74.68
Performance (%)
-
End price
07.11.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - |
| iShares Core DAX® | -1.764% | 2.259% | 15.213% |
| iShares Nasdaq 100 | -1.632% | -0.193% | 3.293% |
| iShares Nikkei 225® | -2.451% | 4.086% | 17.198% |
| iShares S&P 500 | -2.252% | -0.151% | 0.574% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Bank of America Co. from $55.00 to $80.00. They now have an "underperform" rating on the stock.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
07.11.25
07.11.25
€78.87
07.11.26
07.11.26
-
19.09.24
19.09.24

